Aims and background. The diagnostic and therapeutic approach to prostate cancer has evolved rapidly in last decades. Young professionals need an update about these recent developments in order to improve the care of patients treated in their daily clinical practice.Methods. On May 18, 2013, AIRO Giovani (the young section of the Italian Association of Radiation Oncology) organized a multidisciplinary meeting involving, as speakers, several young physicians from many parts of Italy actively involved in the diagnostic and therapeutic approach to prostate cancer. The meeting was specifically addressed to young physicians (radio-oncologists, urologists, medical oncologists) and presented the state-of-the-art of the diagnostic/therapeutic approa...
Objectives: This report summarises major new findings in the field of prostate cancer (PCa) presente...
Prostate cancer is the second most common cancer in men and a major cause of cancer deaths worldwide...
Prostate cancer is a heterogeneous, indolent or sometimes aggressive tumor. Treatment options are va...
AIMS AND BACKGROUND: The diagnostic and therapeutic approach to prostate cancer has evolved rapidly ...
Keeping current with medical innovations is a challenge that all health care professionals are faced...
Although high sensitive imaging modalities such as MRI and PSMA PET/CT are becoming available for pr...
Prostate cancer (PC) is established as one of the most important medical problems affecting the male...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients....
In this book entitled "Prostate Cancer - Diagnostic and Therapeutic Advances", we highlight many of ...
A multidisciplinary panel of 20 international experts, including urologists, radiation oncologists, ...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients....
BackgroundThe 2015 Coffey-Holden Prostate Cancer Academy Meeting, themed: "Multidisciplinary Interve...
A Prostate Cancer Unit is a place where men can be cared for by specialists in prostate cancer (PC),...
Purpose: Radiotherapy (RT) has an established role in the treatment of prostate cancer patients. Des...
Radiotherapy (RT) for prostate cancer (PC) has steadily evolved over the last decades, with improvin...
Objectives: This report summarises major new findings in the field of prostate cancer (PCa) presente...
Prostate cancer is the second most common cancer in men and a major cause of cancer deaths worldwide...
Prostate cancer is a heterogeneous, indolent or sometimes aggressive tumor. Treatment options are va...
AIMS AND BACKGROUND: The diagnostic and therapeutic approach to prostate cancer has evolved rapidly ...
Keeping current with medical innovations is a challenge that all health care professionals are faced...
Although high sensitive imaging modalities such as MRI and PSMA PET/CT are becoming available for pr...
Prostate cancer (PC) is established as one of the most important medical problems affecting the male...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients....
In this book entitled "Prostate Cancer - Diagnostic and Therapeutic Advances", we highlight many of ...
A multidisciplinary panel of 20 international experts, including urologists, radiation oncologists, ...
Background There are several treatments available to newly diagnosed prostate cancer (PCA) patients....
BackgroundThe 2015 Coffey-Holden Prostate Cancer Academy Meeting, themed: "Multidisciplinary Interve...
A Prostate Cancer Unit is a place where men can be cared for by specialists in prostate cancer (PC),...
Purpose: Radiotherapy (RT) has an established role in the treatment of prostate cancer patients. Des...
Radiotherapy (RT) for prostate cancer (PC) has steadily evolved over the last decades, with improvin...
Objectives: This report summarises major new findings in the field of prostate cancer (PCa) presente...
Prostate cancer is the second most common cancer in men and a major cause of cancer deaths worldwide...
Prostate cancer is a heterogeneous, indolent or sometimes aggressive tumor. Treatment options are va...